Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Polycystic Kidney Disease Clinical Trials
Polycystic Kidney Disease clinical trials are recruiting across 33 cities. Here are the cities with the most active studies:
Polycystic Kidney Disease Trial Phases
14 research organizations are sponsoring polycystic kidney disease trials.
About Polycystic Kidney Disease
Polycystic kidney disease (PKD) is a genetic disorder causing numerous fluid-filled cysts to grow in the kidneys, leading to kidney enlargement and progressive loss of function. Autosomal dominant PKD is the most common form. Treatment includes tolvaptan and management of complications.
Clinical trials are advancing new treatments for polycystic kidney disease. Currently, 16 studies are recruiting a combined 5,650 participants across the United States. Research is being conducted by 14 organizations including PKD Foundation, The Rogosin Institute, University of Maryland, Baltimore and 11 others.
2026 Polycystic Kidney Disease Research Landscape
As of July 2026, the polycystic kidney disease clinical trial landscape includes 16 actively recruiting studies across 33 cities in the United States. These studies are collectively seeking 5,650 participants, with an average enrollment target of 353 per study.
The research spans multiple phases of development: 3 studies are in PHASE2, 2 studies are in NA, 1 study is in PHASE1, 1 study is in PHASE3. The presence of Phase 3 trials indicates that some polycystic kidney disease treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 14 different organizations, including PKD Foundation, The Rogosin Institute, University of Maryland, Baltimore, Children's Hospital of Philadelphia, University of Kansas Medical Center, and 9 others. The large number of sponsors reflects significant research interest and investment in polycystic kidney disease treatment advancement.
Geographically, polycystic kidney disease trials are most concentrated in Rochester, Minnesota (6 trials); Kansas City, Missouri (3 trials); Baltimore, Maryland (3 trials); Chicago, Illinois (3 trials); Jacksonville, Florida (3 trials) and 7 other cities.
Featured Polycystic Kidney Disease Studies
Highlighted recruiting studies for polycystic kidney disease, selected by enrollment size and research scope.
ADPKD Patient Registry
The purpose of the ADPKD Registry is to create an online patient network that includes at least 5,000 people with Autosomal Dominant Polycystic Kidney Disease (ADPKD) who contribute data on their health and other topics. The ADPKD Patient Registry aims to support important scientific discoveries and support patient needs in the following ways: * Connect ADPKD patients with opportunities to join c...
Polycystic Kidney Disease Data Repository
Autosomal dominant polycystic kidney disease (PKD) is the most common inherited kidney disease, affecting more than 400,000 people in the U.S. and 5 million people worldwide. PKD is the 4th most common cause of kidney failure requiring dialysis and/or transplantation. Over half of all PKD patients develop kidney failure by age 60 years, although age of onset of kidney disease varies widely, even a...
PKD Clinical and Translational Core Study
Advances in our understanding of the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD) have opened up possibilities of new therapies to prevent disease progression. High quality clinical investigations in patients with ADPKD, however, pose significant challenges to investigators including limited access to patients with ADPKD,insufficient guidance by experienced investigators an...
Frequently Asked Questions About Polycystic Kidney Disease Clinical Trials
Are there polycystic kidney disease clinical trials near me?
Yes, there are 16 polycystic kidney disease clinical trials currently recruiting across 33+ cities in the United States, including Rochester, Minnesota; Kansas City, Missouri; Baltimore, Maryland. Browse the studies above to find one at a location convenient for you.
How do I join a polycystic kidney disease clinical trial?
To join a polycystic kidney disease clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are polycystic kidney disease clinical trials free?
Yes, participation in polycystic kidney disease clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of polycystic kidney disease treatments are being studied?
Current polycystic kidney disease clinical trials are testing a range of approaches across PHASE2 (3 studies), NA (2 studies), PHASE1 (1 study), PHASE3 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 14 research organizations.
Is it safe to participate in polycystic kidney disease clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov